Another observational study was released supporting the notion that a heartburn drug helps improve clinical outcomes in coronavirus patients. Famotidine, which is used to treat heartburn and is ...

NEW YORK -- Over the past few weeks researchers have been studying a new potential treatment for COVID-19 and it might not be what many people expect. Researchers at Northwell Health have been ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There was no correlation observed between in-hospital ...

More data from observational studies, this time in hospitalized patients, indicated that famotidine (Pepcid AC), which is used to treat heartburn, was associated with improved clinical outcomes in ...

Results from a fully remote randomized, outpatient clinical trial encourage the additional study of the active ingredient in common heartburn medication to help with COVID-19 treatment MANHASSET, N.Y.

Pepcid products are commonly used to prevent and treat heartburn caused by acid indigestion and upset stomach. The main active ingredient in Pepcid is famotidine, which belongs to a class of medicines ...

“Our case series suggests, but does not establish, a benefit from famotidine treatment in outpatients with COVID-19,” the authors concluded. They added, “Future work will investigate potential ...

Please provide your email address to receive an email when new articles are posted on . In hospitalized patients with COVID-19, famotidine was correlated with a lower mortality risk, lower risk for ...

A nearly $21-million government-funded study to see whether a popular over-the-counter heartburn medication could be a COVID-19 remedy has fizzled amid allegations of conflicts of interest and ...

A nearly $21 million government-funded study to see if a popular, over-the-counter heartburn medication could be a covid-19 remedy has fizzled amid allegations of conflicts of interest and scientific ...